In Silico ADME Profiling of Salubrinal and Its Analogues.
- Published in:
- Future Pharmacology, 2022, v. 2, n. 2, p. 160, doi. 10.3390/futurepharmacol2020013
- By:
- Publication type:
- Article
Works matching IS 26739879 AND DT 2022 AND VI 2 AND IP 2
Results: 6
1
2
Primary Obsessive Slowness: A Complex Presentation and Treatment Difficulties.
- Published in:
- Future Pharmacology, 2022, v. 2, n. 2, p. 153, doi. 10.3390/futurepharmacol2020012
- By:
- Publication type:
- Article
3
Pharmacogenetic Perspective for Optimal Gout Management.
- Published in:
- Future Pharmacology, 2022, v. 2, n. 2, p. 135, doi. 10.3390/futurepharmacol2020011
- By:
- Publication type:
- Article
4
Single Cell Plant Model of Equisetum arvense for the Study Antihistamine Effects of Azulene and Sesquiterpene Lactones.
- Published in:
- Future Pharmacology, 2022, v. 2, n. 2, p. 126, doi. 10.3390/futurepharmacol2020010
- By:
- Publication type:
- Article
5
Snake Venom and 3D Microenvironment Cell Culture: From Production to Drug Development.
- Published in:
- Future Pharmacology, 2022, v. 2, n. 2, p. 117, doi. 10.3390/futurepharmacol2020009
- By:
- Publication type:
- Article
6
In Silico Personalized Study for Zolpidem Based on Sex Difference.
- Published in:
- Future Pharmacology, 2022, v. 2, n. 2, p. 99, doi. 10.3390/futurepharmacol2020008
- By:
- Publication type:
- Article